BTA biota holdings limited

us to buy more relenza, page-5

  1. 3,045 Posts.
    Yeah I agree, LANI is going to be the difference between a $3 and $10 share price. It would be nice if BTA owned the lot as DS may be pushing to market the drug themselves (and hence probably miss the large milestone payments).

    Relenza is looking fantastic at the moment. Patents got extended and GSK are actively promoting the drug. I'm looking forward to the new delivery system and increased production.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.